CHINOOK THERAPEUTICS, INC. Annual Operating Income (Loss) in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Chinook Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2022.
  • Chinook Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$72.6M, a 98% decline year-over-year.
  • Chinook Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$252M, a 192% decline year-over-year.
  • Chinook Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$185M, a 86.9% decline from 2021.
  • Chinook Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$99M, a 76.1% decline from 2020.
  • Chinook Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$56.2M, a 182% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$185M -$86M -86.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-27
2021 -$99M -$42.8M -76.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-27
2020 -$56.2M -$36.3M -182% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$20M +$81.4M +80.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-07
2018 -$101M +$5.09M +4.78% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 -$106M -$34.6M -48.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 -$71.9M -$58.3M -430% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 -$13.6M +$5.55M +29.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$19.1M -$4.58M -31.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$14.5M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.